1. |
Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol, 1995, 13(1): 8-10.
|
2. |
Tselikas L, Garzelli L, Mercier O, et al. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease. Diagn Interv Imaging, 2021, 102(1): 19-26.
|
3. |
Hasegawa T, Kuroda H, Sakakura N, et al. Novel strategy to treat lung metastases: Hybrid therapy involving surgery and radiofrequency ablation. Thorac Cancer, 2021, 12(14): 2085-2092.
|
4. |
de Baère T, Aupérin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: Experience in 566 patients with 1037 metastases. Ann Oncol, 2015, 26(5): 987-991.
|
5. |
Genshaft SJ, Suh RD, Abtin F, et al. Society of Interventional Radiology Multidisciplinary Position Statement on percutaneous ablation of non-small cell lung cancer and metastatic disease to the lungs: Endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology. J Vasc Interv Radiol, 2021, 32(8): 1241.e1-1241.e12.
|
6. |
Matsui Y, Hiraki T, Gobara H, et al. Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases. J Vasc Interv Radiol, 2015, 26(3): 303-310.
|
7. |
Vogl TJ, Eckert R, Naguib NN, et al. Thermal ablation of colorectal lung metastases: Retrospective comparison among laser-induced thermotherapy, radiofrequency ablation, and microwave ablation. AJR Am J Roentgenol, 2016, 207(6): 1340-1349.
|
8. |
Chen J, Lin ZY, Wu ZB, et al. Magnetic resonance imaging evaluation after radiofrequency ablation for malignant lung tumors. J Cancer Res Ther, 2017, 13(4): 669-675.
|
9. |
Cazzato RL, Battistuzzi JB, Catena V, et al. Cone-beam computed tomography (CBCT) versus CT in lung ablation procedure: Which is faster? Cardiovasc Intervent Radiol, 2015, 38(5): 1231-1236.
|
10. |
Li XQ, Zhang Y, Huang DB, et al. Value of C-arm computed tomography in radiofrequency ablation of small lung lesions. Genet Mol Res, 2014, 13(3): 6027-6036.
|
11. |
Vogl TJ, Naguib NNN, Gruber-Rouh T, et al. Microwave ablation therapy: Clinical utility in treatment of pulmonary metastases. Radiology, 2011, 261(2): 643-651.
|
12. |
Pereira PL, Masala S, Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Standards of practice: Guidelines for thermal ablation of primary and secondary lung tumors. Cardiovasc Intervent Radiol, 2012, 35(2): 247-254.
|
13. |
Boyer MJ, Ricardi U, Ball D, et al. Ablative approaches for pulmonary metastases. Thorac Surg Clin, 2016, 26(1): 19-34.
|
14. |
Ibrahim T, Tselikas L, Yazbeck C, et al. Systemic versus local therapies for colorectal cancer pulmonary metastasis: What to choose and when? J Gastrointest Cancer, 2016, 47(3): 223-231.
|
15. |
Treasure T. Surgery and ablative techniques for lung metastases in the pulmonary metastasectomy in colorectal cancer (PulMiCC) trial: Is there equivalence? J Thorac Dis, 2016, 8(Suppl 9): 49-51.
|
16. |
Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: Preliminary report. Radiology, 2004, 230(1): 125-134.
|
17. |
Hiraki T, Matsuno T, Kamegawa, et al. Robotic insertion of various ablation needles under computed tomography huidance: Accuracy in animal rxperiments. Eur J Radiol, 2018, 105: 162-167.
|
18. |
Ye X, Fan WJ, Wang ZM, et al. Expert consensus for thermal ablation of pulmonary subsolid nodules (2021 Edition). Zhongguo Fei Ai Za Zhi, 2021, 24(5): 305-322.
|
19. |
Habert P, Di Bisceglie M, Bartoli A, et al. Description of morphological evolution of lung tumors treated by percutaneous radiofrequency ablation: Long term follow-up of 100 lesions with chest CT. Int J Hyperthermia, 2021, 38(1): 786-794.
|
20. |
Spyropoulos AC, Al-Badri A, Sherwood MW, et al. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost, 2016, 14(5): 875-885.
|
21. |
Malloy PC, Grassi CJ, Kundu S, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol, 2009, 20(Suppl 7): S240-S249.
|
22. |
Clasen S, Krober SM, Kosan B, et al. Pathomorphologic evaluation of pulmonary radiofrequency ablation: Proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer, 2008, 113(11): 3121-3129.
|
23. |
de Baère T. Lung tumor radiofrequency ablation: Where do we stand? Cardiovasc Interv Radiol, 2011, 34(2): 241-251.
|
24. |
Zheng A, Yang X, Ye X, et al. Bronchopleural fistula after lung ablation: Experience in two cases and literature review. Indian J Cancer, 2015, 52(Suppl 2): e41-e46.
|
25. |
Tomiyama N, Yasuhara Y, Nakajima Y, et al. CT-guided needle biopsy of lung lesions: A survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol, 2006, 59(1): 60-64.
|
26. |
Kashima M, Yamakado K, Takaki H, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: A single center's experiences. AJR Am J Roentgenol, 2011, 197(4): W576-W580.
|
27. |
Nour-Eldin NE, Naguib NN, Mack M, et al. Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern. Eur Radiol, 2011, 21(1): 197-204.
|